Banco Bilbao Vizcaya Argentaria SA vs Herbalife Nutrition Ltd — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.62 (market cap $157.51B), while Herbalife Nutrition Ltd trades at $11.76 (market cap $1.23B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 128.1× Herbalife Nutrition Ltd's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| BBVA | HLF | |
|---|---|---|
Market Cap | $157.51B | $1.23B |
Sector | Financials | Consumer Staples |
52-Week High | $28.50 | $19.96 |
52-Week Low | $17.96 | $7.75 |
Dividend Yield | 3.8% | — |
Enterprise Value | — | $3.06B |
Signals from Pluang's Aura AI — not financial advice
BBVA trades at $28.545, up 0.69% today, with a bullish technical signal from moving averages but overbought RSI readings. The bank reported strong Q2 2026 earnings, beating estimates with an 11.4% net profit rise, and announced a $2.3 billion share buyback. Revenue growth has been steady, reaching $39.42 billion in 2025, with a net income margin of 26.13% and ROE of 18.5%, though valuation ratios like P/E of 12.98 and P/S of 3.27 suggest moderate pricing.
Outlook remains positive with analyst consensus at 53.85% buy ratings, driven by profitability improvements and strategic initiatives. Key risks include regulatory probes in Spain and antitrust investigations, which could impact sentiment. Investors should weigh solid fundamentals against legal uncertainties for balanced exposure.
Herbalife (HLF) trades at $11.695, up 1.52% on the day, with a bearish technical outlook per moving averages. The company reported Q2 2026 net sales of $1.3 billion, a 5.4% year-over-year increase, though EPS of $0.51 missed estimates. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24. Positive news includes being named to TIME's America's Best Companies 2026 list, but a planned CFO transition in December 2026 introduces uncertainty.
The outlook is mixed; strong sales growth and low valuation metrics offer potential upside, but recent earnings misses, a high debt load, and negative shareholder equity pose significant risks. Analyst consensus leans bullish with 53.84% buy ratings, yet the stock faces headwinds from competitive pressures and margin volatility.
Trailing returns across standard periods
Latest headlines on both assets
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →